Eymard, D, Lebel, F, Miller, M et al. · The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses · 1993 · DOI
Quick Summary
This study compared antibody levels against human herpesvirus 6 (HHV-6) in two groups: people with ME/CFS and people with chronic fatigue who didn't meet the official ME/CFS diagnosis. Researchers found that people with ME/CFS had significantly higher antibody levels against HHV-6, suggesting the virus might play a role in the condition. The study also found that sore throat, headache, and recurrent fatigue were more common in the ME/CFS group.
Why It Matters
Understanding potential viral cofactors in ME/CFS pathogenesis could help explain disease mechanisms and potentially guide treatment approaches. This study provides early evidence for HHV-6 involvement, which may inform future investigations into viral reactivation or chronic viral infection in ME/CFS.
Observed Findings
HHV-6 antibody titers were significantly higher in CDC-defined ME/CFS patients (1:99) compared to chronic fatigue controls (1:15, p=0.007)
Sore throat was reported more frequently in the ME/CFS group
Headaches were more common in the ME/CFS group
Recurrent (rather than constant) fatigue patterns were more characteristic of ME/CFS patients
No significant differences were found in serology for Epstein-Barr virus, cytomegalovirus, herpes simplex virus, or toxoplasma between groups
Inferred Conclusions
Elevated HHV-6 antibody titers may indicate this virus acts as a cofactor in ME/CFS pathogenesis
The symptom triad of sore throat, headache, and recurrent fatigue can help distinguish CDC-defined ME/CFS from other chronic fatigue conditions
HHV-6 warrants further investigation as a potential contributor to ME/CFS
Remaining Questions
Does elevated HHV-6 antibody indicate active viral replication, reactivation, or simply past infection in ME/CFS patients?
What is the temporal relationship between HHV-6 infection and ME/CFS symptom onset?
What This Study Does Not Prove
This study does not prove that HHV-6 causes ME/CFS—elevated antibodies indicate past or present infection but do not establish causation. The small sample size and lack of additional confirmatory testing (such as HHV-6 viral load or PCR) limit the strength of conclusions. Correlation between HHV-6 antibodies and ME/CFS does not exclude other viral or non-viral cofactors.